Tag: PAD
Pioneering Florida limb preservation program laser-focuses on evidence-based, customized care for...
This advertorial is sponsored by Tampa General Hospital.
As the prevalence of peripheral arterial disease (PAD) continues to climb across the U.S. and globally, a...
CPVI course: Learning the latest intricate skills and techniques to treat...
Vascular Specialist attended the SVS Complex Peripheral Vascular Interventions (CPVI) Skills Course and spoke with participants about the hands-on learning experience designed for vascular...
BIO-OSCAR SOC trial examines standard of care in PAD treatment
Biotronik today announced that it has concluded the BIO-OSCAR SOC study evaluating the baseline against which to measure the Oscar multifunctional catheter in treating complex...
Service: Giving back
Pioneering American Venous Forum (AVF) and Eastern Vascular Society (EVS) efforts aimed at breaking down barriers to care and educating patients in economically challenged...
BEST-CLI: Trial results endure in analysis of patients who presented with...
Diabetes affects approximately 70% of patients with chronic limb-threatening ischemia (CLTI) and is associated with more severe presentation, driven mostly by higher rates of...
Research suggests arm vein is the best alternative bypass conduit to...
A new analysis has found arm vein to be the most suitable alternative conduit to great saphenous vein (GSV) in chronic limb-threatening ischemia (CLTI)...
SVN hosts virtual roundtable on PAD awareness
On Tuesday, Sept. 24, The Society for Vascular Nursing (SVN), in collaboration with the PAD Collaborative and the American Association of Wound Care...
Regional societies see presidential changing of the guards
Brajesh K. Lal, MD, assumed the Eastern Vascular Society (EVS) presidency during the 2024 EVS annual meeting. He took over from Kathleen Ozsvath, MD.
Patrick...
Endologix announces 36-month results of DETOUR2 study
Endologix has announced the final 36-month results from the DETOUR2 study—a prospective, single-arm, international, multicentre clinical evaluation of the novel Detour system for fully...
Bolt Medical announces completion of RESTORE ATK and RESTORE BTK pivotal...
Bolt Medical has announced the completion and results of the RESTORE ATK and RESTORE BTK pivotal clinical trials investigating the company's Bolt intravascular lithotripsy...
Two-year LIFE-BTK data show sustained benefits of drug-eluting resorbable scaffold for...
Presented today, late-breaking data from the second year of the LIFE-BTK clinical trial demonstrate the long-term effectiveness of the US Food and Drug Administration...
FDA grants R3 Vascular IDE approval for ELITE-BTK pivotal trial of...
R3 Vascular today announced that the Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval to initiate its ELITE-BTK pivotal trial...
Endoscopic vein harvest under the microscope
Conflicting results open fresh debate around effect of vein harvesting technique on long-term patency of lower extremity bypass grafts.
Two separate analyses that looked at...
Study details aspects of early care improvements after publication of SVS...
An observational study of intermittent claudication (IC) practice patterns before and after publication of the Society for Vascular Surgery (SVS) appropriate use criteria (AUC)...
Novel RCT framework set to improve design and reporting of endovascular...
Pilot testing has shown that a new framework—dubbed Endo-STAR—can be used to describe and standardise endovascular interventions for peripheral arterial disease (PAD) within a...
The Shockwave E8 experience: Featuring the new Shockwave peripheral IVL workhorse
This advertorial is sponsored by Shockwave Medical.
Paul J. Foley III, MD, a vascular surgeon and director of the non-invasive vascular lab at Doylestown Hospital...
Pulse IVL system US pivotal trial enrolls first patient
Amplitude Vascular Systems (AVS) recently announced that it has enrolled the first patient in its U.S. pivotal trial for pulsatile intravascular lithotripsy (IVL) therapy....
Laser atherectomy redefined: Breakthrough 355nm technology opens next frontier in treatment
In this supplement, sponsored by AngioDynamics:
The storied history behind the Auryon Atherectomy System
What micro-CT reveals about the effectiveness of the Auryon laser...
Smoking: BEST-CLI trial points to protective effect against MALE in those...
An analysis of the BEST-CLI randomized controlled trial (RCT) found that smokers with chronic limb-threatening ischemia (CLTI) should be preferentially treated with open bypass...
The CLTI conundrum: My spirited journey through the CLTI saga
Welcome to the CLTI Chronicles, a saga of mystery, medicine and misadventures in limb salvage unfolding weekly in my office, where the drama of...
Eastern Vascular Society presidency transfers from Ozsvath to Lal
Brajesh K. Lal, MD, assumed the Eastern Vascular Society (EVS) presidency during the 2024 EVS annual meeting in Charleston, South Carolina (Sept. 19–22).
The professor...
VQI analysis of CLTI practice following BEST-CLI finds no pick up...
A Vascular Quality Initiative (VQI) analysis of evolving practice in the wake of the BEST-CLI trial demonstrated no increase in the rate of surgical...
‘Select CLTI patients may be safely treated in the office-based lab’
Results from a single-center analysis show the outpatient setting met SVS objective performance goals.
A retrospective study of endovascular interventions performed for chronic limb-threatening ischemia...
Vascular Specialist–September 2024
In this issue:
‘Select CLTI patients may be safely treated in the office-based lab’: Single-center analysis finds outpatient setting met SVS objective performance goals
...
Shockwave Medical expands US peripheral IVL portfolio with enhanced catheter
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the full U.S. launch of its Shockwave E8 peripheral intravascular lithotripsy (IVL) catheter, following...
The top 10 most popular Vascular Specialist stories of August 2024
In August, the most read stories from Vascular Specialist included a research letter addressing ‘alarmingly high’ mortality rates in chronic limb-threatening ischemia (CLTI) patients; a new...
Stepping up for vascular health: Challenge commences
The 2024 SVS Foundation’s Vascular Health Step Challenge kicked off Sept. 1 with over 400 registrants committed to walking 60 miles throughout September in...
Study: Social support associated with better PAD health outcomes
Patients with peripheral arterial disease (PAD) reporting lower levels of social support experience worse health outcomes, a new Yale-led study finds.
Social support is thought...
New ESC guidelines combine peripheral arterial and aortic diseases for first...
The European Society of Cardiology (ESC) has today published its 2024 guidelines for the management of peripheral arterial and aortic diseases (PAAD), evaluating these...
SVS Foundation’s Step at VAM challenge raises more than $30,000
The recent Vascular Annual Meeting (VAM 2024) was more than a gathering of medical professionals to discuss advancements in vascular health. It featured the...
‘Choosing the right devices for the right patients’: Surgeon-scientist secures NIH...
Michael Conte, MD, recently used his 2024 Veith Lecture to call on young vascular surgeons on the peripheral arterial disease (PAD) frontlines to drive...
Vascular Specialist–August 2024
In this issue:
‘Choosing the right devices for the right patients’: Surgeon-scientist secures NIH funding to develop MRI technique for precision PAD care
SVS...
SCOREPAD seeks to address ‘alarmingly high’ mortality in CLTI patients with...
A new research letter underscores the need to improve long-term survival following lower extremity revascularization for chronic limb-threatening ischemia (CLTI), setting out a randomized...
SVS urges revisions for independent cardiology certification board
The Society for Vascular Surgery (SVS) has expressed conditional support for cardiology establishing an independent certification board but objects to provisions in the current...
Acellular tissue-engineered vessel granted FDA Regenerative Medicine Advanced Therapy designation for...
Humacyte recently announced it has been granted Regenerative Medicine Advanced Therapy (RMAT) designation from the US Food and Drug Administration (FDA) for its investigational...
Grasping the nettle: The need to tackle PAD problem head on...
Huge opportunities abound for vascular surgeons to take a leadership role on the frontlines of a developing peripheral arterial disease (PAD) treatment crisis in...
Vascular Specialist–July 2024
In this issue:
Grasping the nettle—huge opportunity for vascular surgeons to take the lead on the frontlines of peripheral arterial disease (PAD) treatment crisis,...
The top 10 most popular Vascular Specialist stories of June 2024
In June, the most read stories from Vascular Specialist included key reports from the 2024 Vascular Annual Meeting (VAM; June 19–22) covering TEVAR, CEA...
Humacyte’s ATEV granted FDA Regenerative Medicine Advanced Therapy designation for advanced...
Humacyte recently announced it has been granted Regenerative Medicine Advanced Therapy (RMAT) designation from the US Food and Drug Administration (FDA) for its investigational...
Walk for PAD awareness this September
Registration for the Society for Vascular Surgery (SVS) Foundation’s 2024 Vascular Health Step Challenge is now open. The Foundation is hosting the third annual...
Young vascular surgeons on the PAD frontier: ‘This is the time...
Huge opportunities abound for vascular surgeons to take a leadership role on the frontlines of a developing peripheral arterial disease (PAD) treatment crisis in...
Vascular Specialist@VAM Conference Edition 3
In this issue:
Chickasaw Nation study exemplifies how diversity can boost patient access to specialized vascular care
Young vascular surgeons on the PAD frontier:...
Chickasaw Nation study exemplifies how diversity can boost patient access to...
A “feasible and reproducible” intervention bundle characterized by surveys, provider education and patient screening has demonstrated the potential to not only identify gaps in...
Toe and flow session aims to break down barriers to multidisciplinary...
“If you had cancer you would go to a cancer center where you would get a multidisciplinary approach,” SVS President Joseph L. Mills, MD,...
Vascular Specialist@VAM Conference Edition 1
In this issue:
The Crawford Forum: Quality in care is this year’s critical issue
National Coverage Determination: Data and discussion come at key moment...
VAM 2024: Enhancing clinical practice and patient interaction in CLTI
A key event on informed decision-making in chronic limb-threatening ischemia (CLTI) promises to be a highlight of the 2024 Vascular Annual Meeting (June 19–22). Funded...
SVS launches registration for 3rd annual CPVI Skills Course
The Society for Vascular Surgery (SVS) has officially launched registration for the annual Complex Peripheral Vascular Initiatives (CPVI) Skills Course. The first course launched...
AVS receives IDE approval from FDA for pivotal intravascular lithotripsy study
Amplitude Vascular Systems (AVS) announced today that it has received an investigational device exemption (IDE) from the Food and Drug Administration (FDA) to begin...
From the editor: House of Cards
On Jan. 22, 2024, the American Heart Association (AHA) and the American College of Cardiology (ACC), together with three other major cardiology societies, submitted...
The role of deep venous arterialization comes under scrutiny
"Every so often in vascular disease, disruptive technologies come along and the question really is, ‘Is this going to make a big impact on...
PAD guideline update from ACC, AHA and others centers multispecialty care
New multisociety clinical practice guidelines for the management of lower extremity peripheral arterial disease (PAD) have been published online in the Journal of the...
Studies highlight need for tailored treatment options for women with peripheral...
New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral arterial disease (PAD), including endovascular therapy and...
‘Who let a vascular surgeon in the room?’: Leadership in the...
Leading vascular surgeons from across the globe contributed pearls of wisdom on how to go about tackling inevitable turf battles from other specialties practicing...
Paclitaxel controversy: Yes, device restrictions did cause harm
“Unfortunately, we are doing worse for our patients today,” were the sobering thoughts of Eric Secemsky (Boston, United States) during a late-breaking presentation in...
Study details link between increased functional status and improved survival in...
Increasing functional status in vascular patients fitted with a prosthesis after amputation was incrementally associated with improved survival, a retrospective analysis of a 10-year...
The top 10 most popular Vascular Specialist stories of March 2024
In March, the most read stories from Vascular Specialist include a new analysis which suggests of a ‘lack of reach’ of vascular voices within...
FDA Breakthrough Device designation granted for DynamX BTK for use in...
Elixir Medical has announced Breakthrough Device designation by the Food and Drug Administration (FDA) for its novel DynamX BTK System, an implant for use...
Bentley, Cook Medical enter US distribution agreement for BeBack device
Cook Medical and Bentley today announced a distribution agreement for the BeBack crossing catheter in the U.S., with Cook assuming commercial responsibilities for the...
Multi-society PAD Pulse Alliance aims to highlight importance of patient education
Society for Vascular Surgery (SVS) experts are spearheading initiatives as part of the multispecialty PAD Pulse Alliance and its Get a Pulse on PAD...
New analysis points to lack of vascular surgical voices in news...
A new study set to be aired at the 2024 Society for Clinical Vascular Surgery (SCVS) annual meeting (March 16–20) in Scottsdale, Arizona, sheds...
IVUS use in claudicants not associated with improved outcomes, claims data...
The use of intravascular ultrasound (IVUS) for the treatment of claudication doubled over a four-year period but there was “no clear relationship between IVUS...
The top 10 most popular Vascular Specialist stories of February 2024
In February, the most read stories from Vascular Specialist include a study of metformin and its potential as the first-ever medical treatment that can...
Endologix initiates postmarket study of the Detour system
Endologix has announced the initiation of the Percutaneous transmural arterial bypass (PTAB)1 postmarket study. This study marks the beginning of a comprehensive postmarket study...
Trial assessing AI-powered tissue microsensor technology in PAD begins enrollment
Sensome has announced enrollment of the first patients into a feasibility clinical study using the Clotild smart guidewire in peripheral arterial disease (PAD). Clotild was designated...
Breakthrough Device designation granted for Efemoral scaffold system designed to treat...
Efemoral Medical has announced the granting of Food and Drug Administration (FDA) Breakthrough Device status for its novel Efemoral vascular scaffold system (EVSS) designed...
The top 10 most popular Vascular Specialist stories of January 2024
In January, the most read stories from Vascular Specialist include a U.S. Aortic Research Consortium analysis of F/BEVAR preoperative risk factors in AAAs/TAAAs; a...
‘Get a Pulse on PAD’: Multi-society public awareness campaign launched
The Society for Vascular Surgery (SVS), in partnership with three other medical societies operating in the vascular disease space that form the PAD Pulse...
UK MHRA update: Paclitaxel-coated device increased mortality risk is withdrawn for...
Following a review, the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) has updated guidance on the use of paclitaxel-coated devices stating that such devices...
Serration angioplasty associated with reduced recoil in infrapopliteal arteries compared with...
A study comparing the extent of early infrapopliteal recoil after serration and plain balloon angioplasty has found the former produces “substantially less” arterial recoil...
International collaboration unveils updated PAD guidelines in diabetic foot ulcers
The International Working Group on the Diabetic Foot (IWGDF), the European Society for Vascular Surgery (ESVS) and the Society for Vascular Surgery (SVS) have...
First procedures announced in study of novel peripheral IVL system
FastWave Medical has announced the successful completion of enrollment for its first-in-human (FIH) study with the company’s peripheral intravascular lithotripsy (IVL) technology.
The prospective, single-arm...
New Florida vascular chief sets vision aimed at improving outcomes through...
This advertorial is sponsored by Tampa General Hospital.
Early on, Jean Bismuth, MD, acquired a passion for vascular surgery from a world-class source. Back in...
BEST-CLI: A year down the road
A dedicated session at the 2023 VEITHsymposium (Nov. 14–18) in New York City aimed to unpack the ways in which clinical practice and attitudes...
SCAI, SIR, SVS jointly publish proceedings from multispecialty peripheral IVUS roundtable
Proceedings from an expert consensus roundtable that discussed the benefits of intravascular ultrasound (IVUS) in lower extremity revascularization procedures were released today in the...
Centers for Medicare & Medicaid Services grants Transitional Pass-Through payment for...
Endologix recently announced that the Centers for Medicare & Medicaid Services (CMS) has granted a Transitional Pass-Through (TPT) payment for the Detour system, effective...
Ego, logistics, money: Overcoming barriers to a successful wound care program
Proper integration of primary care physicians (PCPs) in the multidisciplinary care of vascular wounds is going to play an increasingly important role as the...
Society for Vascular Surgery addresses latest mainstream media reports on atherectomy
The Society for Vascular Surgery (SVS) has issued a statement addressing the latest reports published by ProPublica on atherectomy use in the U.S.
The nonprofit...
SVS receives CMSS grant to advance diagnostic excellence
The Society for Vascular Surgery (SVS) has received a $100,000 grant from the Council of Medical Specialty Societies (CMSS) to promote diagnostic excellence across...
Changing course: The natural history of tibial claudication comes under scrutiny...
In the end, reflected Michael S. Conte, MD, “it’s not the evidence.” The leading vascular surgeon and peripheral arterial disease (PAD) expert made the...
The top 10 most popular Vascular Specialist stories of November 2023
In November, the most read stories from Vascular Specialist include a reassessment of which carotid revascularization treatment modality is best after the recent Centers...
VOYAGER PAD analyses shed light on use of rivaroxaban in high-risk...
New analyses from the VOYAGER PAD clinical trial in both high-risk and fragile patients and those with and without comorbid coronary artery diseases (CAD)...
SVS Foundation step challenge helps place lens on ‘under-appreciation’ of country’s...
“We have a critical problem in America, which is the under-appreciation of peripheral arterial disease ,” says Vikram Kashyap, MD, on his first time...
Vascular Specialist–November 2023
In this issue:
Carotid revascularization: Getting to the right decision
SVS reveals proposed changes to Society bylaws
Meta-analysis: The complete patient-level dataset on paclitaxel and...
Cyclical-pressure Topical Wound Oxygen therapy emerges as a proven wound-healing device...
This advertorial is sponsored by AOTI.
Enrico Ascher, MD, and Natalie Marks, MD, currently combine for close to 60 years of vascular surgery practice experience...
DETOUR1 and DETOUR2 pooled analysis of bypass system reveals primary rate...
Endologix has announced results from a pooled analysis of the DETOUR1 and DETOUR2 studies evaluating percutaneous transmural arterial bypass (PTAB) with the Detour system.
The Detour system...
Use of IVUS reduces patient risk of MALE or death by...
This advertorial is sponsored by Philips.
The benefits of utilizing intravascular ultrasound (IVUS) in peripheral vascular interventions has been widely demonstrated in the literature. In...
LimFlow announces agreement to be acquired by Inari Medical
LimFlow announced today that it has entered into a definitive agreement to be acquired by Inari Medical.
A press release details that, under the terms...
CLTI: European cohort study provides ‘strong positive evidence’ for surgery over...
A recently published study has shown that lower limb bypass surgery offered a significantly higher probability of amputation-free survival and wound healing compared with...
For Diabetes Month, diabetes resources for SVS members, patients
November is National Diabetes Month. Because SVS members treat patients with the condition—and its complications—the Society has numerous educational resources available.
“Diabetes and Vascular Disease”...
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and...
Data from a patient-level meta-analysis—a factor in the Food and Drug Administration’s (FDA) recent change of position on the use of paclitaxel-coated devices to...
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and...
Data from a patient-level meta-analysis—a factor in the US Food and Drug Administration’s (FDA) recent change of position on the use of paclitaxel-coated devices...
Multicenter study points to favourable safety and efficacy of radial access...
New research examining the safety and efficacy of using radial access for peripheral artery interventions has found that radial access allows early ambulation and...
Vascular Health Step Challenge emerges as beacon of awareness and action
This September, 533 people put their feet to the ground to raise awareness about peripheral arterial disease (PAD) as part of the SVS Foundation’s...
EVS 2023: New data chart underrepresentation of women at the head...
The underrepresentation of women vascular surgeons in national clinical trial leadership formed the central theme of data coming out of a new study that...
Popliteal artery lesions: Two-year results from European DCB catheter registry announced
“We face a scarcity of data evaluating endovascular therapy for isolated popliteal artery lesions, known as a difficult vessel bed to treat as we...
When women are PIs: A story foretold on the vascular frontlines
“Multifactorial” issues persist in gender representation in vascular leadership and trial enrollment, leading women vascular surgeons tell Vascular Specialist.
"We would have fewer untoward side...
Submit ideas for VAM 2024 educational sessions
Organizers of VAM 2024 want members to consider what the modern-day vascular surgeon needs to know for optimal patient care and professional success. What’s...
Coding and complex PAD: Register today for two SVS courses
Limited spots remain open for two popular SVS courses coming in October: the Complex Peripheral Vascular Interventions (CPVI) Skills Course on Oct. 1–2 and...
Step off Friday for SVS Vascular Health Step Challenge
The month of September begins Friday and with it, the SVS Foundation’s Vascular Health Step Challenge.
The initiative challenges participants to walk 60 miles—representing the...
SVS members get ready for second annual vascular health awareness event
September's Vascular Health Step Challenge is fast-approaching, and SVS members are preparing to step up to meet it.
The challenge benefits the SVS Foundation,...
Light-activated drug-coated balloon granted FDA approval for clinical study
Alucent Biomedical has announced that the Food and Drug Administration (FDA) granted an investigational device exemption (IDE) for a U.S. clinical study of AlucentNVS,...
Newest JVS peer-review title appoints editor-in-chief
The Journal of Vascular Surgery (JVS) has announced the appointment of Anahita Dua, MD, as the editor-in-chief of the Journal of Vascular Surgery-Vascular Insights...
Endologix announces first patients treated with the Detour system
Endologix has shared in a press release that the first patients underwent percutaneous transmural arterial bypass (PTAB) using the Detour system since Food and Drug...
SVS responds to New York Times article on overuse of vascular...
In an official Society response, SVS President Joseph Mills, MD, tackles recent coverage in the mainstream media of inappropriateness in vascular care.
There have been...
Long-awaited FDA update finds data do not support excess mortality risk...
In a letter to healthcare providers dated July 11, 2023, the Food and Drug Administration (FDA) communicates that the risk of mortality associated with...
Surmodics receives FDA approval for the SurVeil drug-coated balloon
Surmodics has announced the receipt of Food and Drug Administration (FDA) approval for the SurVeil drug-coated balloon (DCB).
A company press release notes that the...
Vascular Verification Program registers first four hospitals in US—including UCSF
UC San Francisco Medical Center (UCSF) is among the first four hospitals in the U.S. to be verified as part of the American College of...
Two-year DETOUR2 study results presented at VAM 2023
Endologix has announced the 24-month results of the DETOUR2 study, presented at VAM 2023, the annual meeting of the Society for Vascular Surgery (SVS),...
BEST-CLI investigators implore a move beyond endo vs. open ‘battle’ in...
The principal investigators behind the BEST-CLI trial struck a conciliatory tone during the inaugural Frank J. Veith Distinguished Lecture yesterday morning in which they...
Sex-related disparities in lower-extremity revascularization outcomes brought into focus
Women are more likely to undergo reintervention after lower extremity revascularization for peripheral arterial disease (PAD) compared to male patients with similar limb salvage...
BEST-CLI vs. BASIL-2: Different questions yield different answers
Medical editor Malachi Sheahan III, MD, takes a look at seemingly conflicting results from the landmark BEST-CLI and BASIL-2 trials, and asks what they...
‘Nobody believed us’: Vascular giant discusses overcoming skeptics to make specialty-defining...
Malachi Sheahan III, MD, Vascular Specialist’s medical editor, speaks to living legend and limb-salvage pioneer Frank J. Veith, MD, on the contents of his...
The top 10 most popular Vascular Specialist stories of May 2023
Last month, Vascular Specialist most piqued reader interest with a commentary from the editor-in-chief on why he supports the decision by the Southern Association for Vascular...
Vascular Specialist–June 2023 VAM special
In this VAM 2023 preview issue:
The Vascular Annual Meeting (VAM) beckons: "Our annual gathering is almost here. After months of planning, our premiere...
Adding 8–12mm diameter devices to the Shockwave Peripheral Intravascular Lithotripsy toolkit
This advertorial is sponsored by Shockwave Medical.
Mazin Foteh, MD, contrasts the benefits of Shockwave Medical’s new Shockwave L6 Peripheral Intravascular Lithotripsy Catheter alongside those...
New ‘biopsychosocial’ roadmap set out to address PAD treatment and mental...
A recent proposal has called for “whole-person, multidisciplinary interventions” after an interrogation of the interplay between lower extremity peripheral arterial disease (PAD) and mental...
Government Grand Rounds: Educating through advocacy
Since the initial launch of the Cancer Moonshot in 2016, the cancer community has made tangible progress towards ambitious goals, including accelerating scientific discovery...
BASIL-2 points towards endovascular-first revascularization strategy in CLTI patients
A question from Manj Gohel, MD, from Cambridge University Hospitals in Cambridge, England, on what the 2023 Charing Cross (CX) International Symposium audience should...
Surmodics announces successful first patient use of Sublime radial access microcatheter
Surmodics has announced that Ankur Lodha, MD, an interventional cardiologist at the Cardiovascular Institute of the South in Lafayette, Lousiana, and Pradeep Nair, director...
The BeBack crossing catheter: A ‘game-changer’ in endovascular PAD practice
This advertorial is sponsored by Bentley.
Crossing chronic total occlusion (CTO) lesions is a challenging procedure. The BeBack crossing catheter—Bentley’s first product to be...
SVS member named 2023 Presidential Leadership Scholar
Society for Vascular Surgery (SVS) member Anahita Dua, MD, has been named a Presidential Leadership Scholar for 2023.
She is one of 60 scholars in...
On 45th anniversary, CX Symposium chairman credits Chicago vascular surgical tandem...
The occasion of a seminal meeting held in Chicago by former Society for Vascular Surgery (SVS) Presidents John J. Bergan, MD, and James S.T....
SCVS 2023: DAPT shows higher survival rate in patients with low...
A retrospective cohort study presented at the 2023 Society for Clinical Vascular Surgery (SCVS) Annual Symposium in Miami (March 25–29) has found lower-extremity bypass...
Results from PROMISE II pivotal trial published, reinforcing ‘ transformational value’...
Results from the PROMISE II pivotal trial investigating transcatheter arterialization of the deep veins using the LimFlow system in so-called no-option chronic limb-threatening ischemia...
SCVS 2023: Endovascular-first or -only approach to all CLTI patients ‘is...
Michael S. Conte, MD, one of the foremost experts in the field of peripheral arterial disease (PAD), took attendees of the 2023 annual meeting...
Florida hospital targets lingering disparities in limb salvage with region’s first...
This advertorial is sponsored by Tampa General Hospital.
Operating in Tampa, Florida, Charles J. Bailey, MD, and his partners in the Division of Vascular Surgery...
Shockwave Medical announces US launch of new peripheral IVL catheter
Shockwave Medical announced the full U.S. commercial availability of the Shockwave L6 peripheral intravascular lithotripsy (IVL) catheter following clearance by the Food and Drug Administration (FDA).
A...
New VOYAGER PAD analysis confirms consistent benefit of low-dose rivaroxaban plus...
Data from a new prespecified analysis of the phase III VOYAGER PAD clinical trial show that low-dose rivaroxaban plus aspirin resulted in a 33%...
‘Urgent action needed’ to improve implementation of guideline-directed medical therapy for...
Almost one-half of the patients receiving a peripheral vascular intervention (PVI) in the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry between...
More than a research project: The vascular trainee’s role in tackling...
One of my earliest clinical experiences with vascular disease was as a high school student shadowing at a busy urban hospital in Detroit. A...
The top 10 most popular Vascular Specialist stories of January 2023
In January 2023, most popular among the Vascular Specialist readers were several stories from the recent Southern Association for Vascular Surgery meeting, including a report of data shared to demonstrate...
Patients with claudication receive more ‘aggressive’ surgical management in high-competition regions,...
Demonstrating the “susceptibility” of care delivery to regional market competition, M. Libby Weaver, MD, presented the case that intermittent claudication (IC) is a “novel...
VQI study leader highlights virtue of multispecialty gathering of best longitudinal...
Daniel Bertges, MD, talks to Vascular Specialist about recent findings from his work investigating the IN.PACT Admiral drug-coated balloon (DCB). He related how they...
Vascular Specialist–February 2023
In this issue:
Educate, and educate, and educate again: The continuing quest for appropriate venous care (p. 1 and 6)
Likes, dislikes and reposts:...
Early data show ‘dramatic improvement’ in amputation-free survival after initiation of...
This advertorial is sponsored by Tampa General Hospital.
In cases of acute limb ischemia (ALI), time is of the essence, says Charles J. Bailey, MD—from...
SVS Foundation board approves latest pilot programs to help underserved
The SVS Foundation has awarded grants to two Society for Vascular Surgery (SVS) members to help them serve the underserved as part of the...
PRELUDE-BTK subanalysis highlights superior lumen gain, greater volumetric blood flow using...
Cagent Vascular has announced the results of a comparative subanalysis of the PRELUDE-below-the-knee (BTK) study versus plain balloon angioplasty.
The study was led by Marianne...
NIH funding for vascular surgeon-scientists: ‘We need more funded vascular surgeons...
Presenting at the 2023 Southern Association for Vascular Surgery (SAVS) annual meeting in Rio Grande, Puerto Rico, Amin A. Mirzaie—a pre-medical student at Emory...
The year in review: 2022 was an amazing 12 months for...
Despite any number of challenges, the Society for Vascular Surgery (SVS) had a hugely successful 2022 and looks forward to a bright 2023.
Executive Director...
BEST-CLI: Analysis finds correlation between WIfI stage four CLTI and reports...
The BEST-CLI dataset has revealed a correlation between wounds, ischemia and foot infection (WIfI) stage and poorer quality of life due to mental, rather...
Bentley launches rebranded crossing catheter
Germany-based endovascular device company Bentley announced the launch of the BeBack crossing catheter—formerly known as the GoBack—designed for the treatment of heavily calcified lesions...
Human-tissue engineered blood vessels remain durable at six years in PAD...
Mid-term results from a phase II study of surgical bypass using the Human Acellular Vessel (HAV) demonstrated an overall secondary patency rate at 72...
JVS group: Further changes in store for 2023
The planned changes for 2023 for the Journal of Vascular Surgery publications continue the momentum that began in mid- 2022. As former Editor-in-Chief Peter...
SVS Foundation changes name of program aimed at providing care for...
The Society for Vascular Surgery (SVS) Foundation program formerly known as VISTA has a new name. VISTA—an acronym for Vascular Volunteers In Service To...
Vascular community starts process of wrestling with findings from BEST-CLI
One of the earliest multispecialty public gatherings of the vascular community following the release of the first results from the BEST-CLI randomized controlled...
‘Impressive’ 12-month Flex vessel prep data presented at VEITHsymposium
VentureMed Group, a medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for peripheral arterial disease (PAD), announced...
VSGBI spotlights data-driven financial incentives for PAD revascularization
The President’s Symposium at the Vascular Society of Great Britain and Ireland (VSGBI) annual scientific meeting (Nov. 23–25) in Brighton, England, saw Rob Sayers,...
Paclitaxel DCB performs well in ‘challenging anatomy’ of femoropopliteal in-stent restenosis,...
The IN.PACT Admiral drug-coated balloon (DCB) shows promising results in treating femoropopliteal in-stent restenosis (ISR) in a Society for Vascular Surgery (SVS) Vascular Quality...
Efemoral Medical closes financing round to fund ongoing study of its...
Efemoral Medical has today announced the closing of its $4.9 million preferred Series A1 round. Supported by existing investors as well as an experienced...
MVSS 2022: Study finds no link between frailty score and surgical...
A vascular surgery-specific composite frailty score was not associated with with risk of surgical site infection in patients undergoing lower-extremity revascularization in a review...
Vascular Specialist–December 2022
In this issue:
Women in vascular: Annual summit dedicated to tackling key issues related to women’s vascular health and female workforce seeks to ‘enable...
BEST-CLI: Optimal medical therapy adherence ‘well below’ recommended level at baseline
A significant proportion of patients enrolled in the BEST-CLI trial did not meet optimal medical therapy (OMT) guideline-based recommendations at the time of their...
Miss the SVS webinars? Take advantage of the recordings
The Society for Vascular Surgery (SVS) hosts a number of Town Halls, roundtables and webinars for the benefit of its members.
In the past few...
Cyclical topical wound oxygen therapy: A new generation of wound healing...
This advertorial is sponsored by AOTI.
In the beginning, it took a little convincing for Anil Hingorani, MD, to come around to the idea that...
Vascular Specialist–November 2022
In this issue:
First data from BEST-CLI are revealed at the American Heart Association (AHA) Scientific Sessions (p. 1 and 12–13)
The Society...
Chocolate Touch DCB for treatment of peripheral arterial disease receives FDA...
Genesis MedTech Group announced that the Food and Drug Administration (FDA) has approved the Chocolate Touch drug-coated balloon (DCB) percutaneous transluminal angioplasty (PTA) catheter...
‘Significant’ increase in atherectomy use in US largely driven by office-based...
In the United States, atherectomy use in peripheral vascular interventions (PVIs) “more than doubled” from 2010 to 2019, with office-based procedures a “major driver”...
End-stage CLTI: Deep-vein arterialization procedure demonstrates amputation-free survival rate of 66%...
Six-month results from the PROMISE II trial of the LimFlow deep-vein arterialization system showed an overall amputation-free survival of 66%—“well above” the primary endpoint...
Study: Combined antiplatelet, NOAC use linked to worse limb outcomes after...
A new analysis that found combined antiplatelet and novel oral anticoagulant (NOAC) therapy after suprainguinal bypass was associated with worse limb outcomes and equivalent...
The top 10 most popular Vascular Specialist stories of September 2022
September's top stories featured news of a trial to evaluate women's experience of early endovascular aneurysm repair, and of a special women-focused edition...
Only a few seats remain for CPVI hands-on skills course
Only a few spots remain available for the Society for Vascular Surgery’s new Complex Peripheral Vascular Intervention (CPVI) Skills Course. Today—Thursday, Oct. 20—is the...
Vascular surgeons step up for PAD awareness campaign in September
Walking is instrumental to keeping the 60,000 miles of blood vessels in the human body healthy—especially for patients with peripheral arterial disease (PAD). That...
Roundtable for treating CLTI: GLASS will make it clear
The final of three roundtables on treating Chronic Limb-threatening Ischemia (CLTI) will cover the Global Limb Anatomic Staging System—GLASS.
The virtual roundtable, on GLASS staging...
Vascular Specialist–September 2022
In this issue:
No time like the present: The moral imperative for advocacy in vascular surgery (p. 2 and 4)
Corner Stitch: Audible Bleeding...
Treating PAD: ‘Run, don’t walk, to sign up for this incredible...
No matter if you’re a surgeon with a few years—or a few decades—of experience, faculty members of a new, upcoming Society for Vascular Surgery...
PAD: Endovascular revascularization ‘superior or not significantly different’ in terms of...
A real-world analysis of peripheral arterial disease (PAD) patients in Canada indicated open revascularization may not offer a long-term benefit over endovascular intervention. In...
VQI analysis links high levels of neighborhood deprivation to more severe...
Patients categorized as living in neighborhoods with high levels of disadvantage under the Area Deprivation Index (ADI) measure of community adversity have more advanced...
Study is first to elucidate lower-limb amputation epidemiology in a Latin...
A study recently published in the World Journal of Surgery claims to be the first to provide comprehensive population-level data on the epidemiology of lower-extremity...
Limb salvage in focus: New VAM lectureship, born of a pioneering...
It all started around the late 1970s, early 1980s. Back then, recalls Frank J. Veith, MD, the notion of aggressively pursuing limb salvage in...
Vascular experts establish appropriate use of IVUS in peripheral interventions
Royal Philips today announced an important milestone in the evolving standard of care for treating patients with peripheral vascular disease: the establishment of the first-ever...
Selution SLR receives second FDA IDE approval
Selution SLR, MedAlliance’s sirolimus-eluting balloon, has received conditional Food and Drug Administration (FDA) investigational device exemption (IDE) approval to initiate its pivotal clinical trial...
Digging deep into DOACs for PAD post-revascularization in fight to stave...
This advertorial is sponsored by ACHL.
“It’s really sad—but it’s true: In the PAD space, we’re really behind. We’re behind in our understanding of the...
SVS Vascular Health Step Challenge asks surgeons to walk the walk
Most American adults take an average of 5,000 steps per day. In fact, this simple act—getting out and moving—can be the key to prevention...
Black adults treated for common arterial disease are at greater risk...
About 6.5 million Americans over the age of 40 suffer from peripheral arterial disease (PAD). In the U.S., Black adults in their 50s are...
Female sex is associated with additional treatments following surgery for intermittent...
A new U.S. study has found that female sex is associated with more reinterventions after surgical treatment for intermittent claudication. Additionally, guideline-directed medical therapy,...
Cordis announces start of enrollment in RADIANCY clinical study in Europe
Cordis has announced the start of the European RADIANCY premarket clinical study of a stent system designed for radial access in the treatment of...
PAD: Ra Medical Systems receives FDA 510(k) clearance for the Dabra...
Ra Medical Systems has announced receipt of Food and Drug Administration (FDA) 510(k) clearance for the company’s Dabra 2.0 catheter as part of the...
SVS creates limb salvage-focused Frank J. Veith Lectureship
Next year’s Vascular Annual Meeting (VAM) will include a new named lecture: the Frank J. Veith Lecture, named in honor of former Society for...
New project will develop nanoparticles with imaging and medicine-delivery capabilities to...
A University of Texas at Arlington bioengineer is leading a project to develop biodegradable nanomaterials that will take pictures and deliver medicine to combat...
First results from BEST-CLI poised to reveal ‘very low’ quality of...
An analysis from the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial presented at the 2022 Vascular Annual...
Study demonstrates feasibility, effectiveness of at-home exercise therapy plus cognitive behavior...
A mobile phone-administered, home-based exercise therapy program for patients with intermittent claudication (IC) incorporating cognitive behavior therapy (CBT) was found to be feasible, with...
Researchers report higher three-year amputation and reintervention rates in Black and...
In a study of over 7,000 chronic limb-threatening ischemia (CLTI) patients, researchers found that Black and Hispanic patients had higher three-year amputation and reintervention...
Open surgical bypass to distal targets at the ankle is ‘viable’...
The Vascular and Endovascular Surgical Society (VESS) Paper Session at the Vascular Annual Meeting (VAM) in Boston on Wednesday, June 15, will see Othman...
Revascularization strategy for BTK intervention should hinge on diagnostic modality, LINC...
New data provide “another argument” for the use of intravascular ultrasound (IVUS) in below-the-knee (BTK) interventions. This is according to Michael Lichtenberg, MD, from Arnsberg...
Register today for two SVS courses
Registration has opened—along with early-bird pricing—for two Society for Vascular Surgery (SVS) in-person courses in coding and reimbursement, and peripheral artery disease (PAD) skills....
Medtronic gains FDA nod for IN.PACT 018 DCB
Medtronic has announced approval from the Food and Drug Administration (FDA) for the IN.PACT 018 paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter, a drug-coated...
New long-term data of paclitaxel devices continue to show no increased...
New long-term data from the SAFE-PAD (Safety assessment of femoropopliteal endovascular treatment with paclitaxel-coated devices) study were presented today as late-breaking clinical research at...
Shockwave IVL maintains ‘superiority’ to angioplasty in calcified peripheral disease at...
Shockwave Medical announced today that long-term data from the Disrupt PAD III trial found that superior vessel preparation with intravascular lithotripsy (IVL) led to excellent long-term outcomes...
Tissue samples show paclitaxel effect in minority of CLTI patients receiving...
Paclitaxel effect was witnessed in tissue specimens of a minority of chronic limb-threatening ischemia (CLTI) patients treated with drug-coated balloons (DCBs)—but was not dependent...
The top 10 most popular Vascular Specialist stories in March
Among the posts catching Vascular Specialist readers' eyes last month were the digital flipbook version of our March print edition, a new study looking...
Alucent Biomedical announces first patient enrolled in first-in-human natural vascular scaffolding...
Alucent Biomedical announced in a press release that it has enrolled the first patient in ACTIVATE II, an Australia-based first-in-human clinical trial to evaluate the...
Shockwave Medical announces global launch of new peripheral IVL catheter
Shockwave Medical has announced the global commercial availability of the Shockwave M5+ peripheral intravascular lithotripsy (IVL) catheter after receiving both Food and Drug Administration (FDA) and...
SCVS 2022: WIfI score does not predict successful healing after transmetatarsal...
A higher initial Wound, ischemia, and foot infection (WIfI) classification score at initial presentation in chronic limb-threatening ischemia (CLTI) patients who underwent a transmetatarsal...
Potential ‘new paradigm’ in treatment of long occlusive lesions emerges
Vascular surgeon Lewis Schwartz, MD, has had an interest in biomedical engineering since very early in his career. So his involvement in the early-stage...
PROMISE II U.S. pivotal trial of device designed for ‘no-option’ CLTI...
Enrollment has been completed in the PROMISE II pivotal trial of the LimFlow deep vein arterialization system designed to prevent amputations in so-called "no-option"...
Viabahn use in claudicants with long, complex SFA lesions ‘safe and...
Recently published research indicates that stent grafting with the Viabahn endoprosthesis (W L Gore & Associates) of long and complex superficial femoral artery (SFA) lesions in...
Ra Medical Systems receives FDA approval for increased enrollment in atherectomy...
Ra Medical Systems, a medical device company focused on developing the excimer laser system to treat vascular diseases, has announced that enrollment has reached...
The top 10 most popular Vascular Specialist stories in January
January’s top 10 includes “Our forever plague,” a combined editorial by Malachi Sheahan III, MD, our medical editor, on fake news and science, and...
Index atherectomy interventions for claudication ‘is associated with higher’ reintervention rates...
Atherectomy use during index peripheral vascular interventions in claudicants is associated with higher reintervention rates when compared to other technologies, a newly unveiled study...
Cook Medical receives FDA breakthrough designation for new drug-eluting stent
Cook Medical has received Breakthrough Device designation from the Food and Drug Administration (FDA) on a new drug-eluting stent (DES) for below the knee...
ISET 2022 audience hears latest data on endovascular therapies
At this year’s International Symposium on Endovascular Therapy (ISET), being held Jan. 16–19 in Hollywood, Florida, experts presented an array of late-breaking trial results...
CSI announces development of IVL technology for the treatment of PAD
Cardiovascular Systems (CSI) recently announced that it has made significant progress towards the commercialization of its intravascular lithotripsy (IVL) system for the treatment of...
SVS PAD course postponed
The new Society for Vascular Surgery (SVS) Peripheral Arterial Disease (PAD) Skills Course has been postponed amid the COVID-19 pandemic recent surge in cases,...
Vascular Specialist–December 2021
In this issue:
*This issue went to press before Congress moved to address cuts to Medicare due to kick in Jan. 1, 2022.
"Countdown to...
Smoking status ‘should not deter nor delay’ endovascular intervention in femoropopliteal...
Smoking does not seem to affect reocclusion rates, interval to reintervention and the total number of interventions in peripheral arterial disease (PAD) patients with...
Learn by doing at February SVS PAD workshop
The Society for Vascular Surgery (SVS) Peripheral Arterial Disease (PAD) Workshop in February will feature four hours of hands-on surgical skills training, on 10...
Rise in cardiovascular disease, vascular surgeon burnout presents a public health...
Cases of cardiovascular disease are rising across the U.S., with large disparities seen in ethnic groups and poorer geographical areas. In combination with increased...
Endologix announces completion of enrollment in TORUS 2 study for PAD...
Endologix has completed enrollment in the TORUS 2 investigational device exemption (IDE) clinical study in the U.S., a press release reports.
The TORUS 2 study...
Prediabetes screening: ‘Target of reducing disparities should be geared towards advocacy’
On Aug. 24, the United States Preventive Services Task Force (USPSTF) published the newly updated recommendations regarding screening for prediabetes and type-2 diabetes mellitus.1,2...
First patient enrolled in Disrupt BTK II study for long, calcified,...
Shockwave Medical has announced the start of the Disrupt BTK II postmarket study to assess the safety, effectiveness and optimal clinical use of the Shockwave...
Take advantage of SVS diabetes resources
November is National Diabetes Month. The Society for Vascular Surgery (SVS) has many resources to help its members educate their patients and families and...
Hispanic adults with PAD access inpatient care most often via the...
Hispanic adults hospitalized for treatment of symptoms of peripheral arterial disease (PAD) were more likely to access this care by going to the emergency...
Philips announces large-scale study outcomes on use of IVUS in peripheral...
Royal Philips has announced the results of a new large-scale real-world analysis of Centers for Medicare & Medicaid Services (CMS) data on the health...
WVS 2021: Western Vascular Society names new president-elect
University of Southern California (USC) vascular chief Vincent Rowe, MD, took over as the new president of the Western Vascular Society (WVS)—with University of...
The top 10 most popular Vascular Specialist stories in September
Five-year data from the ACST-2 trial comparing carotid endarterectomy and carotid artery stenting, a report from the Crawford Forum at the 2021 Vascular Annual...
PROMISE I 24-month results ‘validate the benefits of the LimFlow system’
LimFlow has announced 24-month results from the PROMISE I study of the LimFlow percutaneous deep vein arterialization system, confirming “excellent and sustained outcomes” for...
One-year results show ‘superior’ primary patency rate for Eluvia DES compared...
One-year results presented at Vascular Interventional Advances (VIVA) 2021 in Las Vegas (Oct. 5–7) from the EMINENT trial demonstrated the superiority of the Eluvia...
VIVA 2021: IVL ‘consistently’ treats real-world calcium in multiple peripheral vessel...
An interim analysis from the DISRUPT PAD III observational study showed that intravascular lithotripsy (IVL) performs “consistently well” across challenging peripheral vessels, lesions and...
Two-year Ranger DCB data demonstrate ‘sustained, high rate’ of device efficacy
Patients treated with Boston Scientific’s Ranger drug-coated balloon (DCB) sustained “improved primary patency” with fewer reinterventions than those treated with uncoated devices, two-year results...
VIVA 2021: Consensus established for appropriate use of IVUS in peripheral...
A worldwide committee of 40 cross-specialty medical experts achieved what was hailed as the first-ever consensus for the appropriate use of intravascular ultrasound (IVUS)...
Save the date for new PAD skills workshop
September is National PAD Awareness Month, and the Society for Vascular Surgery (SVS) will spend the month not only calling attention to causes and...
First patient enrolled in BIONETIC-I study of iliac artery treatment
Biotronik has announced the first patient enrollment in the BIONETIC-I study of the safety and efficacy of the Dynetic-35 cobalt chromium balloon-expandable stent system...
‘Proceed cautiously in use of DCBs in CLTI patients with advanced...
The last several years have seen ongoing controversy and debate about the risks and benefits of paclitaxel-coated devices (PCDs) for patients with peripheral arterial...
European launch: Medtronic receives CE mark for 200mm and 250mm IN.PACT...
Medtronic has announced the European launch of the 200mm and 250mm IN.PACT Admiral drug-coated balloons (DCBs) following CE mark approval. The product is intended to treat long...
PAD: R3 Vascular reports ‘successful initiation’ of first-in-human study of bioresorbable...
Medical device developer R3 Vascular has reported the "successful initiation" of a first-in-human clinical study evaluating the technical and clinical performance of its Magnitude...
Physicians draw attention to Medicare cuts as PAD Awareness Month kicks...
A coalition of physicians and other interested parties focused on peripheral arterial disease (PAD) has called on Congress and the Centers for Medicare and...
Females were 30% less likely to undergo surgery for PAD, national...
A review of more than 1 million patients receiving vascular surgery over a 16-year period identified significant sex-related disparities in the treatment of abdominal...
USPSTF expands screening recommendation for prediabetes, type-2 diabetes to adults aged...
The United States Preventive Services Task Force (USPSTF) has issued an updated recommendation statement suggesting clinicians screen for prediabetes and type-2 diabetes in overweight...
VAM discussion on latest paclitaxel meta-analysis yields mix of caution, skepticism
A Vascular Annual Meeting (VAM) sponsored session on paclitaxel safety drew a mix of skeptical and cautious responses to the latest meta-analysis from interventional...
Amputation rates higher for people with PAD who are poor or...
Poverty and Black race were associated with higher rates of lower-leg amputation among people with peripheral arterial disease (PAD) who live in metropolitan areas, according to new...
Vascular Quality Initiative launches ‘My PAD’ pilot
The Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) has created “My PAD,” a pilot program for collecting patient-reported outcomes (PROs) from patients...
FDA approves expanded PAD indication for rivaroxaban plus aspirin
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Food and Drug Administration (FDA) has approved an expanded peripheral arterial disease...
Veterans with claudication who undergo revascularization ‘significantly more likely to have...
Patients within the Veterans Affairs Administration healthcare system who underwent an intervention for intermittent claudication (IC) were consistently at three-to-four times greater risk of...
‘Let’s move on to solutions,’ keynote speaker tells diversity, equity and...
Lee Kirksey, MD, issued an unapologetic apology of sorts at the outset of his discussion of diversity, equity and inclusion (DEI) issues. “If I...
Colombian researchers report positive 24-month results for VenoValve
Promising two-year results for an emerging potential prosthetic venous valve replacement—which is about to commence a U.S. pivotal trial—were announced at the Vascular Annual...
Research letter highlights low adoption of supervised exercise therapy for PAD
A research letter published in Circulation: Cardiovascular Quality and Outcomes highlights a “very low” utilization of supervised exercise therapy (SET) in symptomatic peripheral arterial disease (PAD) patients...
VOYAGER PAD: Rivaroxaban plus aspirin should be considered after lower-extremity bypass...
“A strategy of adding rivaroxaban 2.5mg twice daily to aspirin should be considered after lower extremity bypass regardless of conduit type,” concluded Nicholas Govsyeyev,...
PRISTINE registry with Selution SLR sirolimus drug-eluting balloon completes enrollment
MedAlliance has announced completion of patient enrollment in the PRISTINE clinical trial with the Selution SLR 018 drug-eluting balloon (DEB) for the treatment of patients with below-the-knee...
VAM: Industry-sponsored symposia
Industry-sponsored symposia at the Vascular Annual Meeting (VAM) will be presented Wednesday and Thursday evenings and at three breakfast sessions taking place Thursday morning....
Study of amputees finds referral for prosthetics to be an independent...
Prosthetic referral was an independent predictor of long-term survival among patients who had undergone lower-extremity amputation, new findings set to be published in the...
AHA publishes updated scientific statement on PAD
The American Heart Association (AHA) has released a new scientific statement on lower extremity peripheral arterial disease (PAD), focusing on contemporary epidemiology, management gaps, and future directions.
The...
Special session on diversity enters VAM agenda
Over the course of more than a year, diversity, equity and inclusion (DEI) have been brought into sharp focus by a compendium of events...
The year in COVID: VAM to feature 10 talks probing pandemic-related...
After nearly 18 months of life dominated by a worldwide pandemic—one that canceled the 2020 Vascular Annual Meeting (VAM)—VAM 2021 highlights several aspects of...
Introducing patient-reported outcomes into the VQI
Vascular specialists have long recognized that there is more to the treatment of peripheral arterial disease (PAD) than the immediate procedural success and early...
Fighting the good fight: The case for multidisciplinary limb salvage in...
Dramatic increases in rates of diabetes—particularly among Black females—through 2060 underscore the importance of a multidisciplinary team approach to limb salvage, according to Vincent...
Fempop bypass shows reintervention benefit over endovascular therapy for advanced premature...
Femoropopliteal bypass is associated with decreased reinterventions at one year compared to endovascular therapy in patients with advanced premature peripheral arterial disease (PAD). This is...
The top 10 most popular Vascular Specialist stories in May
A pointed letter aimed at electronic health record (EHR) behemoth Epic, an argument in favor of endovascular treatment of ruptured abdominal aortic aneurysms (rAAAs)...
Pearls of wisdom for interns
It’s June and, in less than a month, a swarm of new faces, and freshly minted MDs and DOs will descend upon most academic...
Philips announces positive two-year data from TOBA II BTK clinical trial
Royal Philips recently announced positive two-year results from the TOBA (Tack optimized balloon angioplasty) II below-the-knee (BTK) clinical trial.
The data show the Philips Tack endovascular...
Stenting found to be superior to atherectomy, balloon angioplasty in reducing...
Stenting reduced mortality risk in patients undergoing interventions for peripheral arterial disease (PAD) by more than 30% when compared to plain balloon angioplasty, and...
One-year results from PROMISE I study of LimFlow system in ‘no-option’...
Twelve-month data from the full patient cohort in the PROMISE I study of the LimFlow percutaneous deep vein arterialization (pDVA) system have been...
ACC.21: SAFE-PAD finds no increased risk of death with drug-coated devices
Researchers have found no statistically significant difference in mortality between patients treated with drug-coated devices and non-drug-coated devices in the SAFE-PAD study. Eric Secemsky,...
ACC.21: VOYAGER PAD shows rivaroxaban ‘significantly’ reduced total ischemic events in...
Rivaroxaban combined with low-dose aspirin led to a significant reduction in the occurrence of total ischemic events in patients with symptomatic peripheral arterial disease...
Intermittent claudication and exercise therapy: A poor SET-up
Many of you may have already heard about the controversial Comparative Billing Reports (CBRs) that have been received by some of our vascular surgery...
The top 10 most popular stories from April
Our April cover story on the links between electronic health records (EHRs) and physician burnout, the continuing problem of manels (or all-male speaking panels)...
MicroStent to treat PAD below the knee receives FDA breakthrough device...
Micro Medical Solutions (MMS) recently revealed Food and Drug Administration (FDA) breakthrough device designation for its MicroStent vascular stent. This novel technology is designed...
Interventions associated with ‘poor’ two-year relief of intermittent claudication symptoms
Peripheral vascular interventions for intermittent claudication were linked to "poor" two-year relief of symptoms in the Vascular Quality Initiative (VQI) database, a new study...
SoundBite peripheral crossing system gains FDA approval
Soundbite Medical Solutions has announced Food and Drug Administration (FDA) 510(k) approval for the SoundBite crossing system—Peripheral (SCS-P) with the 0.014” active wire (14P).
The...
PAD: Endologix acquires PQ Bypass
Endologix recently announced completing the acquisition of PQ Bypass, a medical technology company pioneering a first-of-its-kind technology that addresses severe peripheral arterial disease (PAD).
PQ...
Lessons in PAD care from VA vascular surgeons
The care of patients with peripheral arterial disease (PAD) is challenging and costly. Every practicing vascular surgeon knows that when patients present with ulcerations,...
Surmodics announces first patient uses of two Sublime radial access platform...
Surmodics recently announced the successful first uses in patients for two devices within its Sublime radial access platform: the Sublime radial access guide sheath and...
Study identifies ‘critical need’ for guidelines on appropriate use of atherectomy
No data currently exist to support the use of atherectomy over other procedures for the treatment of peripheral arterial disease (PAD), and the healthcare...
SVS SET: PAD patient walks away from pain
Ice, cold and snow make it tough to walk outside in Lansing, Michigan, right now. So, jokes Doug Giller, he is wearing a path...
Coaches ‘integral’ to SVS SET app program
“A good coach will make his players see what they can be rather than what they are.” Those are words ascribed to football coach...
Supervised Exercise Therapy: There’s an app for that
Call it timing on several fronts, each part coming together for the benefit of patients with peripheral arterial disease (PAD).
Included in the mix was...
Postmarket study of sirolimus-eluting balloon enrolls first patient
MedAlliance has announced enrollment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon Selution SLR for the treatment...
Veterans study: No evidence of increased risk of death with use...
A study of more than 10,000 U.S. veterans with peripheral arterial disease (PAD) undergoing endovascular interventions in the femoropopliteal segment found that rates of...
How to succeed in vascular surgery: A guide for the aspiring...
Disclaimer: The views expressed here do not reflect those of Mayo Clinic, the Society for Vascular Surgery, Vascular Specialist, or even the author, for...
Walking can relieve leg pain in people with PAD
Exercise can play an important role in treating peripheral arterial disease (PAD), a recent review by Amy Harwood, PhD, from the Centre for Sport and...
Target 2021: SVS councils and committees drill down on key goals...
While there is little doubt the pandemic has impacted each vascular surgeon and the SVS as a Society in numerous ways, the commitment and...
‘Successful’ first-in-human use of the Efemoral scaffold system announced
Efemoral Medical has announced the first-in-human (FIH) use of the company’s Efemoral Vascular scaffold system (EVSS) with FlexStepv technology in the EFEMORAL I FIH...
WIfI score found to be accurate across racial groups
The wound, ischemia and foot infection (WIfI) score is as accurate a predictor of risk for limb loss in Black people as it is...
Revascularization ‘improves’ walking performance in claudicating PAD patients
Revascularization of the lower extremity improves hemodynamics, walking performance, quality of life and calf-muscle pathology in claudicating patients with peripheral arterial disease (PAD), researchers...
VOYAGER PAD: Rivaroxaban plus aspirin versus aspirin alone among CLTI patients...
In one of the latest sub-analyses from the VOYAGER PAD trial, investigators found that rivaroxaban plus aspirin versus aspirin alone in the high-risk population...
Previously described patient-centered clinical success measure after revascularization for diabetic foot...
Patient-centered clinical success after lower-extremity revascularization for people with diabetic foot wounds was achieved among 63% of patients in a new analysis—but researchers suggest...
Intravascular lithotripsy ‘superior’ to PTA in acute procedural success out to...
The DISRUPT PAD III randomized controlled trial (RCT) provides the largest level-one evidence for the treatment of heavily calcified femoropopliteal arteries, noted William Gray,...
Latest VOYAGER PAD analysis finds no mortality and improved limb outcomes...
Given the absence of a safety signal in data from the VOYAGER PAD trial, a new analysis examined the potential benefit of drug-coated device...
Utilize new SVS Branding Toolkit
The new SVS Branding Toolkit—a robust set of tools designed to help members communicate their roles in comprehensive vascular care—is now available exclusively and...
Janssen applies to FDA for new indication to expand use of...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the Food and Drug...
New analysis finds DCBs lead to greater four-year survival after fempop...
Patients treated with a paclitaxel-coated balloon saw greater survival, freedom from amputation and amputation-free survival through four-year follow-up after their initial femoropopliteal revascularization operation...
Hodgson: Bringing appropriateness into sharper focus
In 2019, Kim Hodgson, MD, kicked off his presidential year by placing appropriateness and quality of care under the microscope. His turn organizing the...
Vascular Specialist–October 2020
In this issue:
Special interview: Kim Hodgson, MD, discusses his SVS presidency, his appropriateness-in-care agenda, the new SVS SET app, and his post-presidential priorities...
VA system delivers high quality services for veterans
Vascular surgery in the Veterans Health Administration has always been a robust service, developing into a mature specialty around the time of the Vietnam...
‘No signal of increased risk of long-term mortality’ with paclitaxel-coated Luminor...
An ad hoc, two-year analysis of the EffPac study found no signal of increased risk of long-term mortality, nor any adverse events, within two years...
Disproportionately more women are affected by depression when pursuing specialty PAD...
A disproportionately higher percentage of women are affected by depressive symptoms when they seek specialty care for new or worsening peripheral arterial disease (PAD)...
High level of heterogeneity found in randomized PAD trial antithrombotic regimens
A recent systematic review showed that randomized trials comparing different types of peripheral endovascular arterial intervention have a high level of heterogeneity in their...
Diversity, equity and inclusion: Disparities in medicine and vascular surgery
Recent months have yielded a conversation on systemic racism perhaps unlike any other before. We’ve learned about how it manifests across society, how it...
‘If I had gone along the path advised, I would never...
Some of the formative educational experiences described by Olamide Alabi, MD, read like textbook examples of the subtleties many see as baked into U.S....
Doubted as a doctor during mid-flight medical emergency and once asked:...
In a vascular surgery career spanning 20 years, Vincent Rowe, MD, has seen it all: Tending to patients at bedside, the vascular surgical services...
‘Casting a wider net’ when researching genetic and molecular factors of...
For vascular surgeon and research scientist Elsie Gyang Ross, MD, the world of data science might hold some of the answers to the kind...
‘Improving disparities in healthcare is not a matter of slapping some...
Andrew Gonzalez, MD, had a heart for underserved and under- resourced communities embedded early. The son of a pediatric hematologist mother who worked at...
Black patients in areas with lowest PAD rates disproportionally at higher...
It’s among the most topical areas of discussion in current U.S. cultural life: Black people face disparities in terms of healthcare outcomes. And the...
SVN to host virtual annual meeting July 15
The Society for Vascular Nursing (SVN) 38th Annual Conference—a virtual meeting—will be held from 6 to 9:30 p.m. Central Daylight Time Wednesday, July 15.
In...
International Lecture: Endovascular colossus discusses new PAD therapy
A new therapy of hydration and oncotic pressure of plasma helped 100% of certain elderly peripheral artery disease (PAD) patients in terms of pain,...
SVS pilots SET app for peripheral artery disease patients
Doctor-prescribed and -supervised exercise therapy is going digital. The Society for Vascular Surgery (SVS) will begin piloting a ground-breaking app for Supervised Exercise Therapy...
SVS in transition: A look back, a look ahead
Each Society for Vascular Surgery (SVS) president wishes for a memorable annual meeting, outgoing SVS president Kim Hodgson, MD, noted during his State of...
TOBA III clinical trial results published
Intact Vascular has announced the peer-reviewed publication of its Tack optimized balloon angioplasty (TOBA) III 12-month clinical trial results in the Journal of Vascular Surgery.
The multi-center, single-arm,...
Technology drives vascular future
Decades ago, “picture” phones were an idea straight out of science fiction. As the saying goes, the future is now. FaceTime and Skype are...
Quality: Global Vascular Guidelines pocket guide coming soon
The Global Vascular Guidelines (GVG), extensively researched and written by an international committee of leading vascular experts, will soon be available as a pocket...
Clopidogrel exposure along with aspirin and rivaroxaban should be ‘minimized or...
“More bleeding with background clopidogrel, even if not severe by adjudication, may be associated with broad consequences, including discontinuation of therapies. In the absence...
Combining aspirin with rivaroxaban reduces risk equally in presence or absence...
In stable atherosclerosis, a combination of aspirin plus rivaroxaban provided a similar relative degree of benefit on coronary, cerebrovascular and peripheral endpoints in patients...
Aspirin plus rivaroxaban significantly lowers adverse events in PAD revascularization
Treatment with aspirin plus rivaroxaban following lower-extremity revascularization in patients with peripheral arterial disease (PAD) leads to a 15% reduction in the risk of...